Clinical characteristics of the EIA—UQ patient subgroup indicated accentuated initial cardiovascular risk: besides high incidence of hypertension, dyslipidaemia and diabetes mellitus, baseline cardiac biomarker (hsTnT) and necroenzymes levels (CK, CKMB, ASAT, LDH) were also elevated. The gene discussed is ABCB7; the disease is diabetes mellitus.